Company profile
Iksuda Therapeutics
Creating class-leading ADCs with enhanced tumor specificity
- Industry
- Biotechnology Research
- Employees
- 43
- Headquarters
- Newcastle Upon Tyne, Tyne and Wear
- LinkedIn followers
- 4,814
- Office locations
- 1
Iksuda Therapeutics company summary
Iksuda Therapeutics is a company in the Biotechnology Research industry, headquartered in Newcastle Upon Tyne, Tyne and Wear. On LinkedIn the company has around 43 employees and 4,814 followers. Its listed specialties include Antibody-Drug Conjugates, PermaLink™, Conjugation Chemistry, Cancer research, ADCs.
What technology does Iksuda Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Iksuda Therapeutics
Through our highly experienced ADC Research & Development Team, we are building a pipeline of class-leading ADCs with superior therapeutic index (TI) for difficult-to-treat cancers. Our approach is to develop the best ADC for any given target or tumor sub-type rather than 'technology-driven ADCs'. All our ADCs incorporate tumor-selective release & activation of the most relevant payload according to mechanism, optimizing anti-cancer efficacy and enhancing patient safety.
Specialties
Where is Iksuda Therapeutics located?
Iksuda Therapeutics lists 1 location.
Compare companies similar to Iksuda Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Iksuda Therapeutics iksuda.com | Biotechnology Research | 43 | - | Newcastle Upon Tyne, Tyne and Wear |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Iksuda Therapeutics
What does Iksuda Therapeutics do?
Through our highly experienced ADC Research & Development Team, we are building a pipeline of class-leading ADCs with superior therapeutic index (TI) for difficult-to-treat cancers. Our approach is to develop the best ADC for any given target or tumor sub-type rather than 'technology-driven ADCs'. All our ADCs incorporate tumor-selective release & activation of the most relevant payload according to mechanism, optimizing anti-cancer efficacy and enhancing patient safety.
How many employees does Iksuda Therapeutics have?
Iksuda Therapeutics has around 43 employees on LinkedIn.
Where is Iksuda Therapeutics headquartered?
Iksuda Therapeutics is headquartered in Newcastle Upon Tyne, Tyne and Wear.
Build a lead list from companies like Iksuda Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.